PLTR · DEEP VALUE BRIEFING

Palantir Technologies Inc. (PLTR)

published Oct 31, 2026 · price now $167.99 · market cap $431B

PESIMISTIK · medium confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Briefing

Palantir appears to be an exceptional, asset-light business, but at $184 and roughly 159 times trailing earnings, the stock offers no demonstrated margin of safety. Its 82.4% gross margin, mission-critical platforms, government credentials, and high switching costs support a durable franchise. However, the price requires exceptional growth, operating leverage, controlled dilution, and a premium terminal valuation to occur together.

The Risky Analyst correctly highlights that trailing earnings may understate Palantir’s future economics. Yet credible upside is not the same as favorable asymmetry: ordinary multiple compression could produce poor returns even if earnings grow strongly. Technical trends and options positioning do not repair that valuation problem.

Decision: Do not initiate a normal Buffett-style position at $184. Keep Palantir on a high-priority watchlist and reassess using per-share cash flow, dilution, AIP production conversions, and a refreshed reverse DCF. Existing holders should control concentration rather than make an all-or-nothing decision.

Adjudication of the Debate

Strongest case for owning Palantir

The Risky Analyst makes several valid points:

  • Palantir is already profitable, unlike many speculative AI companies.
  • 82.4% gross margin, 22% ROE, and 18.3% ROA indicate attractive, asset-light economics.
  • Gotham, Foundry, and AIP integrate data, governance, models, security, and operational workflows. They are not simply interfaces to third-party AI models.
  • Government and defense experience creates credibility that hyperscalers or newer competitors cannot instantly reproduce.
  • Once embedded, Palantir can become costly and operationally risky to replace.
  • Earnings may grow faster than revenue if deployment becomes more repeatable and operating leverage emerges.

The Risky Analyst is also correct that the reverse DCF is not definitive. A fixed discount rate and terminal multiple cannot capture every possible outcome, and interim cash generation adds value. Palantir could outperform the assumptions.

These arguments establish that exceptional execution is plausible. They do not establish that the investor is being compensated for relying on it.

Strongest case for avoiding the shares

The Safe Analyst identifies the decisive issue: valuation creates downside even without business failure.

At approximately 159 times trailing earnings, investors are paying in advance for years of superior growth. The supplied reverse-valuation exercise suggests that roughly 30% annual EPS growth for ten years, followed by a still-premium 30-times terminal multiple, may be needed to support a price near $184 at a 10% required return. That is not a conservative base case.

The Safe Analyst’s illustration is useful: if estimated trailing EPS of roughly $1.16 rose 50% but the valuation fell to 60 times earnings, the resulting price would be around $104. This is not a forecast, but it shows that strong business performance need not prevent a substantial loss.

Other important limitations include:

  • Gross margin does not reveal how much revenue ultimately reaches shareholders after sales, implementation, engineering, support, and stock compensation.
  • The reported 663.4% ROIC is distorted by a small accounting capital base and the expensing of internally developed intangible assets. It indicates low capital intensity, not a sustainable 663% reinvestment return.
  • Current revenue growth, AIP conversion rates, net retention, deployment efficiency, free cash flow per diluted share, and diluted-share growth were not supplied.
  • At this valuation, those missing figures are essential rather than optional.

The burden of proof belongs with the buyer when the price requires extraordinary execution.

Neutral Analyst’s useful refinement

The Neutral Analyst correctly rejects two extremes.

The Safe Analyst cannot prove that severe downside is the most likely outcome, and Palantir may retain a premium valuation if it becomes a durable operating layer for government and enterprise AI. Competition from Microsoft, Amazon, Google, and Databricks is meaningful, but those businesses are not necessarily direct substitutes in every security-sensitive deployment.

At the same time, position sizing does not transform an overvalued security into a value investment. A 0.5% speculative allocation may be defensible for a risk-tolerant growth portfolio, but it belongs in a speculative sleeve—not in a Buffett-style core allocation.

Accordingly, the Neutral Analyst’s optional token position is reasonable only under a different mandate. It does not change the decision for a long-term value investor seeking a measurable margin of safety.

Risk Commentary

Business risk: comparatively moderate

Palantir does not show evidence of financial distress or a broken operating model. Its profitability, high gross margin, asset-light structure, and government franchise reduce the risk of permanent business impairment.

Potential long-term business risks remain:

  • Hyperscaler bundling and distribution could reduce new-customer wins.
  • Governance and orchestration tools may become more standardized.
  • Complex deployments may remain labor- and support-intensive.
  • Government procurement can be slow and politically exposed.
  • Stock-based compensation could transfer a meaningful portion of growth to employees rather than shareholders.

Switching costs protect existing installations, but they do not ensure that new customers select Palantir or that acquisition economics remain attractive.

Valuation risk: exceptionally high

Overpayment is the principal risk. Palantir can remain a wonderful company while producing mediocre or negative shareholder returns if growth falls modestly short or the multiple normalizes.

A high-quality compounder may justify only a modest 10–15% discount to conservatively estimated intrinsic value. Here, no such discount has been demonstrated. The current price instead appears to capitalize much of the optimistic scenario.

That makes the payoff unfavorable under Buffett’s framework: investors bear substantial downside from ordinary disappointment while much of the upside from successful execution is already embedded in the price.

Market and options signals: secondary

The shares remain above the approximate 200-day moving-average region in the mid-$150s, suggesting the longer trend has not fully broken. However, the decline from approximately $209, trading below the short-term trend, and weakening dip-buying indicate near-term multiple pressure.

The 0.96 put/call open-interest ratio and expensive downside volatility show demand for protection. They do not prove either undervaluation or impending decline. Elevated implied volatility also makes protective puts an expensive risk-control mechanism.

Neither technical support nor defensive options positioning establishes intrinsic-value support.

Refined Investor Plan

Original plan, adjusted

Maintain the original conclusion: do not initiate a normal-sized position at $184. The debate strengthens confidence in Palantir’s business quality but does not supply the missing evidence needed to relax valuation discipline.

A token speculative position may be acceptable for an investor explicitly seeking high-risk growth exposure, but it should not be characterized as a Buffett-style value purchase.

What to monitor over the next one to four quarters

  1. Revenue quality
  • Separate commercial and government growth.
  • Look for sustained commercial expansion without weakening government momentum.
  1. AIP conversion
  • Track movement from pilots and demonstrations to durable production contracts.
  • Emphasize contract size, duration, expansion, and remaining deal value over customer announcements.
  1. Operating leverage
  • Require improving operating and free-cash-flow margins without underinvestment in R&D, support, or security.
  • Determine whether deployment is becoming repeatable rather than remaining highly customized.
  1. Per-share economics
  • Prioritize free cash flow and earnings per diluted share.
  • Monitor stock-based compensation as a percentage of revenue and year-over-year diluted-share growth.
  • Confirm that repurchases reduce the net share count rather than merely offset employee issuance.
  1. Competitive evidence
  • Watch pricing concessions, lost contracts, implementation costs, expansion rates, and customer preference for bundled hyperscaler offerings.
  • Strong retention and cross-workflow expansion would support the moat.
  1. Valuation
  • Rerun the reverse DCF after each earnings report.
  • Use several growth, margin, dilution, discount-rate, and terminal-multiple scenarios.
  • Do not buy merely because the price approaches $160 or the 200-day moving average. A lower quotation is useful only if conservative intrinsic value rises above it by an adequate margin.

Existing holders

  • A modest position can be held while monitoring execution.
  • A position that has become a major portfolio concentration should be trimmed toward a predetermined maximum, considering taxes and individual circumstances.
  • Avoid relying on expensive protective puts as the primary risk control.
  • Do not average down solely because the stock has fallen from a recent high.

Lesson Applied

The key lesson is to separate admiration for the company from expected return on the stock. A large addressable market is not a forecast; high gross margins do not automatically prove a wide moat; and early operating leverage cannot be extrapolated indefinitely.

Likewise, fear of missing a transformational winner should not override current fundamentals. The disciplined response is not to deny Palantir’s potential, but to demand evidence that future growth will accrue to shareholders on a per-share basis—and to pay a price that does not require near-perfect execution.

Final Stance: AVOID

Avoid new Buffett-style purchases at $184. Palantir belongs on the watchlist because of its exceptional business quality, but the present valuation lacks a demonstrated margin of safety.

Scorecard

Overall 3.57 out of 5, weighted as shown.

DimensionWeightScoreWhat it measures
Business Quality30%4.25 / 5High returns, profitability, and Piotroski health support durability.
Valuation Support30%1.00 / 5Blends current price against available intrinsic value anchors and valuation ratios.
Financial Strength20%5.00 / 5Balance-sheet resilience reflects leverage and liquidity staying within safe ranges.
Growth Durability20%5.00 / 5Recent revenue, earnings, and free cash flow growth indicate how durable expansion looks.

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2025), updated Nov 14, 2026; the market price was $167.99. Values are estimates, not predictions.

Owner earnings (Buffett)

Discounts owner earnings: the cash the business generates for its owners after the spending needed to keep it running.

Value per share: $23.05 / $32.93 / $32.93 (conservative / base / optimistic)

Starting Owner Earnings$3.3B
Growth: conservative / base / optimistic (2023–2025)10.0% / 10.0% / 10.0%
Projection10 years
Discount rate8.5%
Terminal growth2.5%
Shares outstanding2574M
The history the growth rates come from (8 years)
2018−$614M
2019−$569M
2020−$1.2B
2021−$403M
2022−$176M
2023$137M
2024$325M
2025$1.4B

Free cash flow

Discounts reported free cash flow: operating cash flow minus capital expenditure.

Value per share: $5.83 / $68.25 / $69.24 (conservative / base / optimistic)

Starting Free Cash Flow$3.1B
Growth: conservative / base / optimistic (2020–2025)-58.0% / 29.6% / 30.0%
Projection10 years
Discount rate9.3%
Terminal growth4.5%
Shares outstanding2574M
The history the growth rates come from (8 years)
2018−$52M
2019−$178M
2020−$309M
2021$321M
2022$184M
2023$697M
2024$1.1B
2025$2.1B

This briefing is from Oct 31, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

Run a fresh briefing →Watch the video briefingGet the iPhone appGet the Android app

Margin of Safety Weekly

Every Saturday: the market’s temperature, what the great investors filed, and the week’s research.

Send me the DeepValues Margin of Safety Weekly, one email every Saturday. I can unsubscribe at any time. Information only, not investment advice. Privacy